Jacqueline Paula Smith - 15 Jan 2025 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jan 2025, 16:09:30 UTC
Prior SEC filing
19 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jacqueline Smith

Key filing fact

Jacqueline Paula Smith filed Form 4 for PETMED EXPRESS INC (PETS) on 17 Jan 2025.

Key facts

  • This page summarizes Jacqueline Paula Smith's Form 4 filing for PETMED EXPRESS INC (PETS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jan 2025, 16:09.

Change

  • Previous filing in this sequence was filed on 19 Aug 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value
$0
Shares
+8,000
Change %
+40%
Price
$0.000000
Shares after
28,099
Date
15 Jan 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of January 15, 2025, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .